Norris Medicines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Norris Medicines Ltd · Outcome · 14 Nov 2026, 11:32 pm
Norris Medicines Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 65.7 (-67.2% YoY | -29.0% QoQ) ■ EBITDA: -22.6 (+53.7% YoY | +19.8% QoQ) ■ EBITDA Margin (%): -34.5 (-1005 bps YoY | -398 bps QoQ) ■ PAT: -36.2 (+49.6% YoY | +8.7% QoQ) ■ EPS (INR): -0.36 (+50.0% YoY | +10.0% QoQ)
Original exchange filing (PDF)
More announcements from Norris Medicines Ltd
- Un-audited financial results for the quarter and half year ended 30th September, 2026 · 14 Nov 2026
- Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... · 14 Nov 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 30 Sept 2026
- Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 30 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 29 Sept 2026
- Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 2026 · 29 Sept 2026
- Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 2026 · 29 Sept 2026
- Annual Report of the Company for the Financial year 2025-26. · 05 Sept 2026
